Pharmaceutical Economics & Health PolicyManagement of NSAID-induced gastropathy: an economic decision analysis
References (45)
- et al.
Trends in the utilization of non-steroidal anti-inflammatory drugs in the United States 1866–1990
J Clin Epidemiol
(1992) - et al.
Current issues in NSAID therapy
Prim Care
(1990) Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: Prophylactic and therapeutic strategies
Am J Med
(1994)- et al.
Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs
Am J Med
(1988) - et al.
Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial
Lancet
(1988) - et al.
Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models
Am J Med
(1991) - et al.
A review of selected newer nonsteroidal anti-inflammatory drugs
Am Fam Phys
(1994) Nonsteroidal anti-inflammatory drugs and the gut
South Med J
(1996)- et al.
Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers. A one-year study
Dig Dis Sci
(1995) - et al.
Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons
Am J Epidemiol
(1995)
Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study
Arch Intern Med
(1996)
Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury
Am J Med
(1996)
FDA's NSAID class labeling estimate of 4–6% GI adverse reaction annually is not valid, PMA maintains: PMA proposes industry-consensus NSAID label warning
FDA Reports
(301987)
Toward an understanding of NSAID-related adverse events: The contribution of longitudinal data
Scand J Rheumatol
(1996)
NSAID-associated gastrointestinal damage and the elderly
Pract Gastroenterol
(1993)
Assessing and understanding patient risk
Scand J Rheumatol
(1992)
Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs
Ann Intern Med
(1995)
Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients
Am J Gastroenterol
(1997)
Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: A prospective, double-blind, multicenter study
Am J Gastroenterol
(1996)
Drug Utilization Evaluation of Michigan Medicaid claims database (12/1/94–11/30/95)
(1995)
Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials
Arch Intern Med
(1996)
Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine
BMJ
(1988)
Cited by (0)
Copyright © 1997 Published by Elsevier Inc.